Anavex Life Sciences
AVXL
#8125
Rank
A$0.40 B
Marketcap
A$4.37
Share price
5.42%
Change (1 day)
-68.68%
Change (1 year)

Earnings for Anavex Life Sciences (AVXL)

Earnings in 2025 (TTM): -A$73.29 Million

According to Anavex Life Sciences 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$72.46 Million a decrease over its 2023 earnings that were of -A$63.14 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Anavex Life Sciences from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$73.29 Million1.15%
2024 -A$72.46 Million14.77%
2023 -A$63.14 Million-17.49%
2022 -A$76.52 Million22.96%
2021 -A$62.23 Million35.36%
2020 -A$45.97 Million12.65%
2019 -A$40.81 Million29.09%
2018 -A$31.62 Million36.33%
2017 -A$23.19 Million17.11%
2016 -A$19.8 Million20.91%
2015 -A$16.38 Million-6.29%
2014 -A$17.48 Million337.28%
2013 -A$4 Million
2008 -A$7.4 Million106.01%
2007 -A$3.59 Million8848.98%
2006 -A$0.05 Million-79.99%
2005 -A$0.21 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ligand Pharmaceuticals
LGND
A$0.23 B-449.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
A$62.95 M-195.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-A$6.74 Million-89.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
A$0.37 B-671.48%๐Ÿ‡บ๐Ÿ‡ธ USA